Rights and permissions
About this article
Cite this article
Model suggests immunomodulators cost saving in neutropenia. Pharmacoecon. Outcomes News 55, 4 (1996). https://doi.org/10.1007/BF03269880
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269880